Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
January 07, 2021 at 11:03 am
Share
Meso Numismatics, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was USD 11,320 compared to USD 11,916 a year ago. Net loss was USD 846,273 compared to USD 2.682 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.55 a year ago.
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
MESO NUMISMATICS, INC. 
